Kaléo
ApprovedKaléo is a company that passionately pursues meaningful and innovative healthcare products and solutions to empower patients and their families to live fuller, bolder lives.
Founded
2011
Focus
Drug Delivery
About
Kaléo is a company that passionately pursues meaningful and innovative healthcare products and solutions to empower patients and their families to live fuller, bolder lives.
Funding History
3Total raised: $400M
Debt$200MUndisclosedNov 15, 2018
Series B$150MMorningside VenturesMay 15, 2016
Series A$50MMorningside VenturesMar 15, 2014
Company Info
TypePrivate
Founded2011
LocationRichmond, United States
StageApproved
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile